Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target (Q45299199)
Jump to navigation
Jump to search
scientific article published on 25 November 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target |
scientific article published on 25 November 2005 |
Statements
1 reference
Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target (English)
1 reference
1 reference
John S Bett
1 reference
Geoffrey M Goellner
1 reference
Ben Woodman
1 reference
Gregory Pratt
1 reference
Martin Rechsteiner
1 reference
25 November 2005
1 reference
1 reference
15
1 reference
1
1 reference
33-44
1 reference
Identifiers
1 reference
1 reference